Results 111 to 120 of about 33,462 (192)

Pneumococcal vaccine for children [PDF]

Paediatrics & Child Health, 2002
openaire   +2 more sources

Changes and determinants of pneumococcal vaccine uptake in Ethiopia. [PDF]

PLOS Glob Public Health
Mamo BT, Geram FG, Getnet KY, Bonger ZT.
europepmc   +1 more source

Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]

Hum Vaccin Immunother
Giriappa B, Choraria N, Ponce P, Drozd J, Su X, Lei L, Portka M, Pai S, Anderson A, Bickham K, Watson W, McElwee K.   +11 more
europepmc   +1 more source

IAPSM's Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India. [PDF]

Indian J Community Med
Rao CR, Kamath VG, Nadda A, Parida SP, Sharma N, Goel K, Shetty RS, Verma M, Singh AK, Mishra A, Kiran S, Sankhe L, Gupta M.   +12 more
europepmc   +1 more source

Cost-Effectiveness of the Pneumococcal Vaccine in the Adult Population: A Systematic Review. [PDF]

Healthcare (Basel)
Vo NX, Pham HL, Bui UM, Ho HT, Bui TT.
europepmc   +1 more source

Influenza and pneumococcal vaccine hesitancy in the elderly population: results from two representative surveys in Germany. [PDF]

BMC Public Health
Heinemeier D, Schmid P, Eitze S, Betsch C, Vaccination60+ study group.   +4 more
europepmc   +1 more source

Serotype specific pneumococcal vaccine effectiveness in children with sickle cell disease: A two-decade analysis. [PDF]

Vaccine
Zhang Z, Yildirim M, Keskinocak P, Dasthagirisaheb YBS, Hinderstein S, Tran K, Crockett M, Burns M, Johnson H, Popstefanija M, Madoff LC, Pelton SI, Yildirim I.   +12 more
europepmc   +1 more source

Impact of the 13-valent pneumococcal vaccine on <i>Streptococcus pneumoniae</i> serotypes and antibiotic susceptibility in children. [PDF]

J Int Med Res
Shengxin Z, Lin Y, Lei C, Yan Z, Huaying L, Qing L.   +5 more
europepmc   +1 more source

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024. [PDF]

Vaccines (Basel)
Chan KF, Ma TF, Ho JC, Hung IF, Ip MS, Ho PL.   +5 more
europepmc   +1 more source

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8. [PDF]

Clin Infect Dis
Scott PT, Pathirana J, Kato A, Tytus R, Perez CM, Gilchrist NL, Kanou H, Ha Yoo K, Kania G, Nissen M, Russell AF, Fernsler D, Waleed M, Li J, Buchwald UK, Platt HL.   +15 more
europepmc   +1 more source